Storys zum Thema Medizin, Gesundheit
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
Hattersheim, Germany (ots/PRNewswire) - European Medicines Agency Approves 21-Day Dosing Intervals for Adult Haemophilia B Patients Global biotherapeutics leader CSL Behring announced today that the European Medicines Agency (EMA) has approved the new Summary of Product Characteristics, which includes information about new, extended dosing options for IDELVION® ...
mehrCarag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework
Baar, Switzerland (ots/PRNewswire) - The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach CARAG AG, a privately-held Swiss medical device development company, today announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Meeting challenges through basic research
Bern (ots) - Many scientists are currently undertaking work on the Sars-CoV-2 virus. But hundreds of projects supported by the SNSF are already contributing to finding answers to the current health crisis. In Switzerland and around the world, the novel coronavirus has become a priority for scientific research. Projects supported by the Swiss National Science Foundation (SNSF) are no exception. A special call and a ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Towards a Swiss Food Strategy for 2050
Bern (ots) - NRP 69 recommends that the government develop a Swiss Food Strategy for 2050. This strategy should enable the entire population to eat healthy food sourced from a sustainable production and distribution system. Is it possible to follow a healthy diet that includes more vegetables, fruit and nuts while still reducing the environmental impact that consumption has both in Switzerland and abroad? Funded by the ...
mehrIgNova files patent application on antibody against COVID-19
Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...
mehr
Mental Health Care Company COMPASS Pathways Strengthens Leadership Team With Appointment of Trevor Mill as Chief Development Officer
London (ots/PRNewswire) - - Piers Morgan appointed earlier in the year as Chief Financial Officer and Gary Gilmour as Director of Preclinical Research COMPASS Pathways, a mental health care company, announced today that it has made a number of new appointments to its leadership team. Trevor Mill joins the company as ...
mehrZhejiang Hisun Pharmaceutical Co. Ltd
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
Taizhou, China (ots/PRNewswire) - Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA viruses, including Ebola, influenza and COVID-19. No evident adverse reactions have been found since it came into the market. Unlike traditional antiviral drugs, Favipiravir can directly ...
mehrNorgine B.V. Senior Management Changes: Christopher Bath Appointed Chief Operating Officer
Amsterdam (ots/PRNewswire) - Norgine B.V. (Norgine) today announced that Christopher Bath has been appointed Chief Operating Officer (COO) effective 1st July 2020. Chris, who has been Norgine's Chief Financial Officer since 2014, will report to Peter Stein, Chairman and Chief Executive Officer (CEO) of Norgine. He will be responsible for all global operations. Chris ...
mehrThe International Osteoporosis Foundation (IOF)
New Capture the Fracture® partnership aims for 25% reduction in the incidence of hip and vertebral fractures due to osteoporosis by 2025
mehrInvestigational, Once-weekly Insulin Icodec Showed Comparable Efficacy and Safety to Once-daily Insulin Glargine U100 in Phase 2 Trial
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only, excl US For journalistic assessment and preparation before publication. Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue. In the ...
mehrSwitching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice
Bagsværd, Denmark (ots/PRNewswire) - This material is intended for global medical media only, excl US. For journalistic assessment and preparation before publication. - A separate real-world study showed that people with type 2 diabetes on two oral antidiabetic drugs who intensified with a glucagon-like peptide-1 ...
mehr
International Atherosclerosis Society
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
Milan (ots/PRNewswire) - Article and slides can be found at https://www.athero.org/activities/survey or contact Karen Foy (karen.foy@athero.org) A new survey by the International Atherosclerosis Society (IAS) provided a 'snapshot' of the gaps in knowledge among clinicians that limit best practice. This web-based ...
mehrGalderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing
Lausanne, Switzerland (ots/PRNewswire) - Healthcare professionals (HCPs) encouraged to investigate true impacts beyond the visible, empower patients with knowledge and aim for 'clear' (IGA 0) skin to improve outcomes A new expert-authored Galderma report (https://hosted.bmj.com/rosaceabeyondthevisible) released ...
mehrDebiopharm's Novel Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Lausanne, Switzerland (ots) - Takeda will pursue the development of a novel preclinical narrow spectrum microbiome remodeling program, to treat diseases related to dysbiosis of the human gut microbiome Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today an exclusive license agreement ...
mehrDebiopharm partners with Verity Pharmaceuticals for the exclusive US commercialization of Trelstar® for Prostate Cancer
LAUSANNE, SWITZERLAND & WAYNE, PENNSYLVANIA (ots) - Debiopharm, a Swiss-based, biopharmaceutical company, and Verity Pharmaceuticals Inc., a US based specialty pharmaceutical company focused on therapeutic solutions for genitourinary (GU) diseases, today announced having entered into an exclusive agreement that ...
mehrFirst Adjuvanted Quadrivalent Influenza Vaccine by Seqirus Receives EU Approval
Maidenhead, England (ots/PRNewswire) - The European Commission has today given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe. This new vaccine builds on the well-established technology used in an existing adjuvanted trivalent influenza vaccine (aTIV) available in several European countries. aTIV has ...
mehrUCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy
Brussels, Belgium (ots/PRNewswire) - - Underlines UCB's leadership in epilepsy by adding Staccato® Alprazolam, a drug-device-combination with the potential to be the first on-demand, single-use treatment to rapidly terminate an active epileptic seizure - Staccato® Alprazolam could be a potential solution for ...
mehr
Avectas and UC Davis Collaborate on Cell Engineering Technology
Dublin (ots/PRNewswire) - Collaboration will advance Avectas' cell engineering technology leveraging UC Davis' world-class cell membrane characterisation expertise Avectas today announced that it has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterisation of cells engineered with Avectas' proprietary, non-viral SOLUPORE(TM) cell engineering ...
mehrZentiva Expands Production Capacity by Completing Acquisition of Ankleshwar Manufacturing Site
Prague (ots/PRNewswire) - Zentiva Group announces the completion of its acquisition of a manufacturing site in Ankleshwar, India, from Sanofi. The finalization of the deal increases the number of wholly-owned Zentiva production sites worldwide and will enable Zentiva to serve more people who are in daily need of our high quality, affordable medicines. "We are delighted ...
mehrMerck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
Darmstadt, Germany (ots/PRNewswire) - - Merck and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) - Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS International Federation and help connect people affected by the disease, in line with official World MS Day theme MS ...
mehrChina Matters and Tianjin Haihe Media Group Released Co-produced Documentary "A Man on a Rescue Mission against COVID-19"
Tianjin, China (ots/PRNewswire) - At the age of 72, Zhang Boli, a medical professional from Tianjin, was saving lives at the forefront of the COVID-19 response in Wuhan while being saved by others. Doctor Zhang was convinced that traditional Chinese medicine (TCM) could be helpful alongside Western medicine for ...
mehrChina Matters and Tianjin Haihe Media Group Released Co-produced Documentary "Everyday Warriors in Tianjin's Fight Against COVID-19"
Tianjin, China (ots/PRNewswire) - Among the unsung characters in the fight against COVID-19, Qu Lei is the only sign-language interpreter for Tianjin's Press Conference on the pandemic prevention and control. From February 8, Qu was gesturing the latest information of the pandemic to the hearing-impaired audience, ...
mehrChina Matters and Tianjin Haihe Media Group Released Co-produced Documentary "A Port City's Quick Response to COVID-19"
Tianjin, China (ots/PRNewswire) - Tianjin's public health emergency response level was lowered to level-2 on April 30, after almost four months of continuous efforts in COVID-19 prevention and control. As a port city, Tianjin faced drastic challenges during the pandemic. On January 25, Costa Serena, a cruise ship ...
mehr
DERMALOG Identification Systems GmbH
DERMALOG Fever Check at German Baltic Hotel
Usedom and Hamburg, Germany (ots/PRNewswire) - - Picture is available at AP Images ( http://www.apimages.com/ ) - In the course of the Corona pandemic, the hospitality industry has come under increased scrutiny by public authorities. Incidents such as the Covid-19 outbreak in the Austrian town of Ischgl have led to extensive regulations for the safe operation of hotels and restaurants. At the same time, owners are ...
mehrSMART Medical Systems Receives FDA Clearance for Its G-EYE® Colonoscope
Ra'anana, Israel (ots/PRNewswire) - SMART's G-EYE®Colonoscope, incorporating the G-EYE® Balloon Technology which helps control the endoscope's field of view and positioning during colonoscopy, was cleared for marketing in the USA by FDA SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced that the FDA issued 510(k) ...
mehrAcquisition of Debiopharm's investment portfolio company Kaiku Health broadens patient access to digital oncology intervention
Lausanne, Switzerland (ots) - - Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved patient outcomes and experience - Kaiku's acquisition by the Swedish company Elekta allows thousands of cancer treatment centers to gain access to the ...
mehrWSSCC Names New Executive Director
mehrThe Global Center on Adaptation
African Leaders Endorse Plan From Global Center on Adaptation for Africa to Build Climate Resilience Into Recovery From COVID-19 Pandemic
Rotterdam, Netherlands (ots/PRNewswire) - Today, 54 leaders from the African Adaptation Initiative championed by President Ali Bongo Ondimba of Gabon, endorsed the policy recommendations outlined in the brief "Integrated Responses to Building Climate and Pandemic Resilience in Africa". The policy brief was prepared ...
mehrTauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Aberdeen, Scotland and Singapore (ots/PRNewswire) - Minimum dose of hydromethylthionine could slow clinical decline and brain atrophy in behavioural variant Fronto-Temporal Dementia as well as Alzheimer's Disease In a paper published online in the Journal of Alzheimer's Disease ( https://doi.org/10.3233/JAD-191173 ) , TauRx reported that the drug it is developing for ...
mehr